In chondrocytes, activating FGFR3 mutations induce cell cycle arrest and premature senescence, but drive excessive proliferation in associated tumors, including multiple myeloma and bladder cancer ([83] and reviewed in [84]). This evidence concerns the gene FGFR3 and AL amyloidosis.